Meiosis In Cryptococcal Infection

隐球菌感染中的减数分裂

基本信息

  • 批准号:
    9530730
  • 负责人:
  • 金额:
    $ 23.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-03-08 至 2019-02-28
  • 项目状态:
    已结题

项目摘要

ABSTRACT The fungal pathogen Cryptococcus neoformans is responsible for more than half a million deaths worldwide each year largely because of the AIDS pandemic. Epidemiological evidence indicates a high prevalence of non-symptomatic cryptococcal infections in the general population. Fatal systemic diseases often occur through re-activation of latent infections in patients when their immunity is impaired by HIV infection or immunosuppressive therapies. Although Cryptococcus typically grows in a haploid state, large polyploid Cryptococcus cells (mostly 4C and occasionally 8C) are observed in infected lungs and are proposed to promote cryptococcal latency and persistence. These polyploid cells can subsequently give rise to small haploid cryptococcal populations. It is unclear how ploidy reduction occurs in Cryptococcus during infection and whether this process contributes to Cryptococcus reactivation. Our preliminary data indicate that a subpopulation of Cryptococcus cells become large in serum with meiosis mutants showing increased proportion of cells with elevated cell size. Interestingly, we found that large polyploid cryptococcal cells induced by genotoxic stress showed meiosis-like features during de- polyploidization process in vitro. Consistently, blocking meiosis impedes ploidy reduction in vitro. The meiosis mutants also showed reduced fungal burden in the lungs compared to the wild type when polyploid cells were used to inoculate mice. Most excitingly, we found that the meiosis-specific recombinase gene DMC1 is activated in Cryptococcus during infection in the murine model of cryptococcosis. These preliminary data led us to hypothesize that Cryptococcus can respond to the hostile host environment by polyploidization and this fungus can return to normal ploidy through meiosis in a permissive host condition due to HIV infection, generating proliferative haploid progeny and causing fatal systemic infections. Thus the life-cycle associated progression of cryptococcosis might be similar to the gametogenesis process of cancer. In that process, various cancer cells become polyploid in response to genotoxic chemotherapy or radiation therapy. These polyploid tumor cells can de-polyploidize through a meiosis-like process, giving rise to rejuvenated and proliferative cancer cells with normal ploidy. In this exploratory R21 proposal, our objectives are to determine the occurrence of meiosis in Cryptococcus during infection (Aim 1), and to dissect the process of ploidy reduction in this pathogen and to assess the contribution of meiosis to cryptococcal pathogenesis (Aim 2). The proposed work is a stepping stone for further comprehensive investigation into the important and yet poorly understood aspects of cryptococcal disease progression (latency and reactivation).
抽象的 真菌病原体新型隐球菌导致超过 50 万人死亡 每年在世界范围内流行主要是由于艾滋病的流行。流行病学证据表明高 一般人群中无症状隐球菌感染的患病率。致命的全身性疾病 当患者的免疫力因 HIV 感染而受损时,通常会通过重新激活患者的潜伏感染而发生 或免疫抑制疗法。尽管隐球菌通常以单倍体状态生长,但大的多倍体 在受感染的肺部中观察到隐球菌细胞(主要为 4C,偶尔为 8C),建议 促进隐球菌潜伏期和持久性。这些多倍体细胞随后可以产生小的 单倍体隐球菌群体。目前尚不清楚隐球菌在感染过程中如何发生倍性减少 以及这个过程是否有助于隐球菌的重新激活。 我们的初步数据表明,血清中的隐球菌细胞亚群随着时间的推移而变大 减数分裂突变体显示细胞比例增加且细胞尺寸增大。有趣的是,我们发现大 基因毒性应激诱导的多倍体隐球菌细胞在脱细胞过程中表现出减数分裂样特征 体外多倍化过程。一致地,阻断减数分裂会阻碍体外倍性减少。减数分裂 当多倍体细胞被处理时,与野生型相比,突变体还显示出肺部真菌负担减少。 用于给小鼠接种。最令人兴奋的是,我们发现减数分裂特异性重组酶基因DMC1是 在隐球菌病小鼠模型感染过程中,隐球菌被激活。这些初步数据导致 我们假设隐球菌可以通过多倍化来应对恶劣的宿主环境,这 由于艾滋病毒感染,真菌可以在允许的宿主条件下通过减数分裂恢复正常倍性, 产生增殖性单倍体后代并引起致命的全身感染。因此,生命周期相关 隐球菌病的进展可能与癌症的配子发生过程相似。在那个过程中, 各种癌细胞响应基因毒性化疗或放疗而变成多倍体。这些 多倍体肿瘤细胞可以通过类似减数分裂的过程去多倍化,从而产生恢复活力和 具有正常倍性的增殖性癌细胞。在这个探索性 R21 提案中,我们的目标是确定 隐球菌感染过程中减数分裂的发生(目标1),并剖析倍性过程 减少该病原体并评估减数分裂对隐球菌发病机制的贡献(目标 2)。这 拟议的工作是进一步全面调查重要但不充分的问题的垫脚石 了解隐球菌疾病进展的各个方面(潜伏期和重新激活)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiaorong Lin其他文献

Xiaorong Lin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiaorong Lin', 18)}}的其他基金

Develop and Assess mRNA Lipid Nanoparticle Vaccines Against Cryptococcosis
开发并评估针对隐球菌病的 mRNA 脂质纳米颗粒疫苗
  • 批准号:
    10616313
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
Define the molecular bases for cryptococcal adaptation to host conditions by the RAM pathway
通过 RAM 途径定义隐球菌适应宿主条件的分子基础
  • 批准号:
    10627371
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
Investigating a signaling molecule that cooperates with quorum sensing to induce biofilm formation in C. neoformans
研究与群体感应配合诱导新型隐球菌生物膜形成的信号分子
  • 批准号:
    10550504
  • 财政年份:
    2022
  • 资助金额:
    $ 23.93万
  • 项目类别:
Systematic investigation of GPI-anchored mannoproteins in Cryptococcus neoformans
新型隐球菌中 GPI 锚定甘露糖蛋白的系统研究
  • 批准号:
    10117186
  • 财政年份:
    2020
  • 资助金额:
    $ 23.93万
  • 项目类别:
Defining the genetic network governing cryptococcal morphological transition
定义控制隐球菌形态转变的遗传网络
  • 批准号:
    10170231
  • 财政年份:
    2018
  • 资助金额:
    $ 23.93万
  • 项目类别:
Defining the genetic network governing cryptococcal morphological transition
定义控制隐球菌形态转变的遗传网络
  • 批准号:
    10403545
  • 财政年份:
    2018
  • 资助金额:
    $ 23.93万
  • 项目类别:
Defining the genetic network governing cryptococcal morphological transition
定义控制隐球菌形态转变的遗传网络
  • 批准号:
    9923532
  • 财政年份:
    2018
  • 资助金额:
    $ 23.93万
  • 项目类别:
Defining the genetic network governing cryptococcal morphological transition
定义控制隐球菌形态转变的遗传网络
  • 批准号:
    9615729
  • 财政年份:
    2018
  • 资助金额:
    $ 23.93万
  • 项目类别:
The link between dimorphism and virulence in Cryptococcus
隐球菌二态性和毒力之间的联系
  • 批准号:
    9529008
  • 财政年份:
    2017
  • 资助金额:
    $ 23.93万
  • 项目类别:
Meiosis in cryptococcal infection
隐球菌感染中的减数分裂
  • 批准号:
    9355796
  • 财政年份:
    2017
  • 资助金额:
    $ 23.93万
  • 项目类别:

相似海外基金

Mechanisms of balancing the immune response during cryptococcal meningoencephalitis
隐球菌性脑膜脑炎期间平衡免疫反应的机制
  • 批准号:
    10761918
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
Population Structure and Clinical Impact of Multi-strain and Mixed-species Cryptococcal Infections
多菌株和混合物种隐球菌感染的人群结构和临床影响
  • 批准号:
    10724704
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
Host and fungal factors important for the cryptococcal intracellular niche
对隐球菌细胞内生态位很重要的宿主和真菌因素
  • 批准号:
    10717537
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
Therapeutic Agents Targeting Cryptococcal Infections
针对隐球菌感染的治疗药物
  • 批准号:
    10697960
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
Filling gaps in the cryptococcal wall with glycogen and a novel enzyme
用糖原和一种新型酶填充隐球菌壁的间隙
  • 批准号:
    10648839
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了